| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Blogging > Developing a Rule Strategy for Your Blog |
|
E-Folder - Developing a Rule Strategy for Your Blog
If you have a Blog and lots of participants then perhaps you have considered rules to help guide the dia According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product logues? Generally Blogs are places where concepts and ideas are discussed so you might even discuss the ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in otential rules with those who will be participating on your Blog? For instance; What are your thoughts o lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. the New Blog Rule Policy? You might get some interesting answers back too such as; “The Policy is Okay here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe as far as Policies Go? But are you sure you need a policy for this Blog?” If this is the case perhaps yo d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro need to ask yourself the question, are the rules really needed? How often is the Blog abused and how of ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ten do people attack others personal character. You should never ask for input on what to add to rules easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi nd regulations, rather you should ask what could be removed. Why you ask? Well because fewer rules are a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically tually better. Yes, the rules should be reduced to three main rules, like Isaac Asmiov's rules for Robot and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ . Keep it simple and easy to remember; 1.) Be Nice, ie "golden rule" and no swear words 2.) Work hard ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi o stay on topic without self-promoting. 3.) Only original comments here, do not post private emails, ot ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a her people's work. The more simplistic the better is my point and to that point one rule could be to us dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod "Common Sense" as that would be the same as the 1-3 here. Of course common sense is pretty much a dying cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin concept for over regulation, political correctness and over-lawyering. So, in the end why bother to mak tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen rules at all? There are enough forums and blogs out their with similar guidelines and they are pretty s t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel andard, so? Why not just say; "This is a Blog" and we would expect you follow Common Sense and Standard ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust Blog Etiquette? I certainly hope this article is of interest to you and helps you with your rule making y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products session. Fewer rules mean better flow of thought and therefore it makes sense to see if you cannot reduc . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de the number of potential rules for the Blog before you start. And if you can get away with it, then simp elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip y wait to make a set of rules until there is a real issue. Perhaps this will help propel thought in 2007 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Weekend Wealth - Turning Your Part-time eBay Passion Into Big Bucks
|